Suppr超能文献

糖尿病本身并非从菌尿症患者分离出的大肠杆菌对抗生素耐药性的风险因素。

Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.

作者信息

Meiland R, Geerlings S E, De Neeling A J, Hoepelman A I M

机构信息

Department of Acute Medicine & Infectious Diseases, University Medical Center Utrecht, Utrecht, the Netherlands.

出版信息

Diabet Med. 2004 Sep;21(9):1032-4. doi: 10.1111/j.1464-5491.2004.01169.x.

Abstract

AIM

To investigate whether diabetes mellitus is a risk factor for resistance in Escherichia coli isolated from patients with bacteriuria.

METHODS

Data were obtained from a multicentre study. A clean-voided midstream urine culture was collected from 636 women with diabetes, who were between 18 and 75-years-old, attended an out-patient department and had no symptoms of a urinary tract infection. The resistance of E. coli was determined for different antimicrobials. The results were compared with resistance data from routine isolates of E. coli, obtained from women in the same age category, time period and location.

RESULTS

A total of 135 E. coli were isolated from women with diabetes mellitus (mean age 57 +/- 14 years) and compared with 5907 routine isolates of E. coli obtained from female patients visiting an out-patient department (mean age 52 +/- 17 years). The resistance rates of E. coli isolated from diabetic patients and the routine isolates of E. coli to trimethoprim-sulfamethoxazole were 19% and 23%, respectively, to amoxicillin 16% and 32%, to nitrofurantoin 1% and 3%, to ciprofloxacin 0% and 4%, to ofloxacin 0% and 5%, and to norfloxacin 1% and 4%.

CONCLUSION

The resistance of uropathogenic E. coli in non-hospitalized women with diabetes mellitus is not higher than that seen in routine isolates of E. coli. This suggests that diabetes in itself is not a risk factor for resistance.

摘要

目的

调查糖尿病是否为从菌尿症患者中分离出的大肠杆菌耐药性的危险因素。

方法

数据来自一项多中心研究。收集了636名年龄在18至75岁之间、就诊于门诊且无尿路感染症状的糖尿病女性患者的清洁中段尿培养物。测定了大肠杆菌对不同抗菌药物的耐药性。将结果与从同一年龄段、同一时间段和同一地点的女性中获得的大肠杆菌常规分离株的耐药性数据进行比较。

结果

从糖尿病女性患者中总共分离出135株大肠杆菌(平均年龄57±14岁),并与从门诊就诊的女性患者中获得的5907株大肠杆菌常规分离株(平均年龄52±17岁)进行比较。从糖尿病患者中分离出的大肠杆菌和大肠杆菌常规分离株对甲氧苄啶-磺胺甲恶唑的耐药率分别为19%和23%,对阿莫西林的耐药率分别为16%和32%,对呋喃妥因的耐药率分别为1%和3%,对环丙沙星的耐药率分别为0%和4%,对氧氟沙星的耐药率分别为0%和5%,对诺氟沙星的耐药率分别为1%和4%。

结论

非住院糖尿病女性患者中尿路致病性大肠杆菌的耐药性不高于大肠杆菌常规分离株。这表明糖尿病本身不是耐药性的危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验